Ovation Science

Ovation Science FCF/Debt

The Free Cash Flow to Debt Ratio of Ovation Science (OVAT.CN) as of Nov 6, 2026 is -1,839.51 %. In the previous year, Free Cash Flow to Debt Ratio was -3,713.69 % — a change of -50.47% (higher).

FCF/Debt

-1,839.51 %

YoY

-50.47%

Last updated:

Free Cash Flow to Debt Ratio of Ovation Science is 2023 -1,839.51 % . Free Cash Flow to Debt Ratio of Ovation Science was 2022 -3,713.69 % . It decreases by -50.47% higher compared to the previous year.

The Ovation Science FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2017
-57.54 CAD
Jan 1, 2018
-148.21 CAD
Jan 1, 2022
-3,713.69 CAD
Jan 1, 2023
-1,839.51 CAD
The Ovation Science FCF/Debt history
YEARFCF/DebtYoY
-1,839.51 %-50.47%
-3,713.69 %+2,405.70%
-148.21 %+157.56%
-57.54 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ovation Science Stock analysis

What does Ovation Science do? Ovation Science, Inc. generates revenue through the development and sale of topical and transdermal skin products utilizing its patented Invisicare delivery technology. The company offers products under the Ovation brand, ARLO CBD Beauty, and InVibe MD, featuring formulations with hemp seed oil, CBD, THC, and cannabinoid derivatives. These products are distributed through direct sales and licensing agreements, targeting consumers seeking science-based skincare and wellness solutions. The firm leverages its Invisicare technology to create creams and lotions that deliver cannabinoids and hemp seed oil effectively for topical and transdermal use. The company's product portfolio includes ARLO CBD Beauty for skincare and InVibe MD for wellness, both powered by the Invisicare delivery system. Ovation Science licenses its technology and products to third parties while also selling directly under its own brands. The primary market segments are consumers interested in cannabinoid-based skincare and wellness products, with a focus on the efficacy and science-backed nature of their formulations. All products are manufactured and distributed under the company's brand labels, emphasizing the patented delivery system as a key differentiator. Ovation Science, Inc. monetizes its patented Invisicare technology by developing and distributing products containing cannabinoids, hemp seed oil, and synthetic cannabis derivatives. The company's revenue streams come from both direct sales of Ovation-branded products and licensing agreements for its technology and formulations. The firm's focus on topical and transdermal delivery ensures that its products are positioned within the growing market for cannabinoid-infused skincare and wellness solutions, targeting customers who prioritize the science and technology behind their skincare products. Ovation Science is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ovation Science stock

Free Cash Flow to Debt Ratio of Ovation Science is -1,839.51 % in 2023.

Free Cash Flow to Debt Ratio of Ovation Science changed from -3,713.69 % to -1,839.51 %, representing a -50.47% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Ovation Science since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Ovation Science with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Ovation Science

All Key Metrics — Ovation Science